Bionik Laboratories Corp.

Bionik Laboratories Corp. engages in the provision of rehabilitation and mobility solutions to individuals with neurological disorders. Its products include InMotion ARM, InMotion HAND, and InMotion WRIST. The company was founded by Michal Prywata and Thiago Caires on January 8, 2010 and is headquartered in Watertown, MA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bionik Laboratories Corp. engages in the provision of rehabilitation and mobility solutions to individuals with neurological disorders. It operates through the Rehabilitation Products and Service Business, and Rehabilitation Clinics segments. The company was founded by Michal Prywata and Thiago Caires on January 8, 2010 and is headquartered in Watertown, MA.

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (“Bionik” or the “Company”), a robotics company providing neurological functional recovery solutions to stroke survivors and others with mobility challenges, offering its technology to therapists directly and services to patients in its clinical center, is proud to announce the issuance of United States Patent No. 11,744,763 by the United States Patent and Trademark Office (USPTO). This patent, titled "An Apparatus and/or Method for Positioning.

Bionik Laboratories Granted United States Patent for Innovative Rehabilitation Technology

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others with mobility challenges, offering its technology to therapists directly and services to patients in its clinical centers, continues to grow its partnership with Lifepoint Health, announcing today its four new installations of the InMotion® ARM robotic device in Phoenix, Arizona, Sacramento, Califor.

Bionik Laboratories Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, offering its technology to therapists directly and offering services to patients in its clinical centers, today announced it has experienced a significant increase in patient volume at its rehabilitation center, Tower Physical Therapy & Rehab, in Clermont, FL. During the first eight.

Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, offering its technology to therapists directly and offering services to patients in its clinical centers, today announced it has entered into a distribution agreement with Pro-Med Technology LTD, a provider of medical equipment based in Hong Kong. The agreement between the two companies.

Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, offering its technology to therapists directly and offering services to patients in its clinical centers, today announced its InMotion® Robots will be on display at the Korea International Medical & Hospital Equipment Show (KIMES) from March 23 – March 26, 2023.

Bionik Laboratories' InMotion® Robotic Devices on Display at the Korea International Medical & Hospital Equipment Show (KIMES)

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, offering its technology to therapists directly and offering services to patients in its clinical centers, today reported financial results for the third quarter and nine months of fiscal year 2023, ended December 31, 2022.

Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, today reported financial results for the second quarter of fiscal year 2023, ended September 30, 2022.

Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results

Presentation to be Webcast at 9:00 AM (ET), Monday, November 14, 2022

Bionik Laboratories to Present at the Q4 Virtual Investor Summit

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK:BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, today announced the appointments of Richard Russo, Jr. as Chief Executive Officer and President, who previously served as Chief Financial Officer.

Bionik Laboratories Appoints Richard Russo, Jr. as Chief Executive Officer and Dan Gonsalves as Chief Financial Officer

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, today announces the acquisition of a rehabilitation center in Clermont, FL. The center is revenue-producing, profitable and has an existing roster of patients and referral sources. Bionik intends for it to be rebranded to a specialized neuro-recovery center t

Bionik Laboratories Acquires Florida Rehabilitation Center; First in Strategic National Rollout

Company focused on delivering long term value for investors BOSTON, MA / ACCESSWIRE / September 1, 2022 / BIONIK Laboratories Corp. (OTC PINK:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to stroke survivors and others with neurological and mobility challenges from hospital to home, today announced that Richard Russo, Interim CEO, will present a corporate overview at the National Investment Banking Association (NIBA) conference on September 8, 2022. NIBA's 148th Conference will be held at the Margaritaville Hollywood Beach Resort in Hollywood, FL.

BIONIK Laboratories to Present at National Investment Banking Association Conference

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTC Pink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported financial results for the first quarter of fiscal year 2023, ended June 30, 2022. First Quarter FY 2023 Highlights BIONIK's sales pipeline remains at the highest levels in corporate history. Began working on an at-home therapy web app, an extens

BIONIK Laboratories Reports First Quarter Financial Results

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTC Pink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced that Rich Russo, Chief Financial Officer and Interim Chief Executive Officer, will be presenting a corporate overview and meeting with institutional investors at the Q3 Virtual Investor Summit. Event: Q3 Investor Summit Date: August 16 & 17

BIONIK Laboratories Corp. to Present at Investor Summit Group's Q3 Virtual Conference

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to stroke survivors and others with neurological and mobility challenges from hospital to home, announced today that Tampa General Hospital (TGH), a part of the Kindred Healthcare network, has purchased and recently installed an InMotion® ARM/HAND Interactive Therapy System at its Rehabilitation Hospital as part o

BIONIK Laboratories Announces the Sale & Installation of a New InMotion® ARM/HAND Robotic Device to Tampa General Hospital for its Rehabilitation Center

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCPink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported financial results for the fourth quarter and fiscal year 2022, ended March 31, 2022. Fourth Quarter FY 2022 and Recent Highlights BIONIK's sales pipeline remains among the highest levels in corporate history. New patient outcomes data reflecting

BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results

As BIONIK Laboratories (BNKL) marks National Stroke Awareness Month, Interim CEO, Richard Russo, talks about what's next for the companyNew York, New York--(Newsfile Corp. - May 25, 2022) - PCG Digital - Stroke is an enormous public health issue that can strike anyone at any time, regardless of age or health status. Worldwide, stroke is the second leading cause of death and a leading cause of serious long-term disability. According to the American Heart Association, each year stroke affects 800,000 individuals. More than two thirds of stroke survivors receive rehabilitation services after hospitalization....

BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to stroke survivors and others with neurological and mobility challenges from hospital to home, today announced its participation in the American Occupational Therapy Association (AOTA) Conference in San Antonio, Texas from March 31 –April 3, 2022. The company will showcase its InMotion® technology at booth 801. T

BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced the release of a new whitepaper, Using IoT Data to Quantify InMotion® Therapy Gains on Upper Extremity Motor Impairments, detailing the significant clinical effects of InMotion Robotic technology on patient recovery. In

BIONIK Laboratories Reports 15-20% Increase in Therapeutic Gains on InMotion® Robotic Devices in New Patient Outcomes Data Report

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported financial results for the third quarter and first nine months of fiscal year 2022, ended December 31, 2021. Third Quarter FY 2022 and Recent Corporate Highlights BIONIK's potential sales pipeline is currently the strongest it has been in corporate

BIONIK Laboratories Reports Third Quarter Fiscal Year 2022 Financial Results

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced its participation in the American Physical Therapy Association (APTA) Conference in San Antonio, Texas from February 2–5, 2022. At the APTA conference, BIONIK will highlight InMotion®'s ability to deliver intensive ther

BIONIK Laboratories to Participate at the American Physical Therapy Association Conference

TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) (“BIONIK” or the “Company”), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced its unique position to meet the increased recovery demands from stroke patients who have suffered from a severe case of COVID-19. According to a recent study on the impact of COVID-19 on neurological events, m

BIONIK Laboratories InMotion® Robotics Technology Meets the Recovery Demands from an Increase of Stroke Patients Brought on by Severe Cases of COVID-19

TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) (“BIONIK” or the “Company”), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced its participation in the MEDICA Trade Show in Dusseldorf, Germany from November 15–18, 2021. MEDICA, the world forum for the medical industry, brings together leaders in medical technologies and equipment. BIO

BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry

TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB:BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported financial results for the second quarter of fiscal year 2022, ended September 30, 2021. Second Quarter FY 2022 and Recent Corporate Highlights Completed capital raise totaling $5 million in July 2021, plus the consolidation of $3.3 million

BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results

TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced the hiring of a new Regional Sales Director, Tony Bellofatto. Bellofatto is an award-winning Medical Device Sales Representative and Regional Director. He has more than 15 years of experience in orthopedic and

BIONIK Laboratories Announces Commercial Team Addition With Newly Hired Regional Sales Director, Tony Bellofatto

TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced hospitals and other healthcare facilities utilizing InMotion Connect™ have seen a 72% increase in patient sessions on InMotion® robotic devices nationwide since the launch of the proprietary data platform last

News for Bionik Laboratories Corp. Stock (BNKL)